DTC Genomics Targeted by Congressional Investigation

Henry Waxman, chairman of the House Committee on Energy and Commerce, said that the committee is investigating direct-to-consumer genomic companies and has sent letters to three firms — Pathway Genomics, 23andMe, and Navigenics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.